Angiomax (bivalirudin)

DRUG2 trials

Sponsors

The Medicines Company

Conditions

Cardiovascular DiseaseCoronary Artery Bypass SurgeryThrombosis

Phase 2

Study Of Angiomax In Infants Under Six Months With Thrombosis

CompletedNCT00043277

The Medicines CompanyThrombosis

Start: 2002-08-31End: 2004-12-31Target: 25Updated: 2006-02-01

Phase 3

Angiomax in Patients With HIT/HITTS Type II Undergoing CPB

CompletedNCT00079508

The Medicines CompanyCardiovascular Disease, Coronary Artery Bypass Surgery

Start: 2004-04-30Updated: 2011-11-10